|
2016 Conference Publication Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a reviewKalas, Timothy S. and Wyld, David (2016). Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast International Hotel, Gold Coast, Queensland, Australia,, Gold Coast, QLD Australia. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646 |
|
2016 Conference Publication A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication A prospective 2-year experience of a medical oncology advanced trainee in QueenslandLadwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. |
|
2016 Conference Publication The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic PseudoprogressionLadwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication A single center experience of cardiac metastasis from neuroendocrine tumors (net)Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646 |
|
2016 Conference Publication How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET DiagnosisWyld, D., Plage, S., Burge, M., Broom, A., Lwin, Z., McDade, H. and Cubitt, A. (2016). How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2016 Conference Publication A systematic review and meta-analysis of patient reporting outcomes in clinical practiceRoberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4 |
|
2016 Conference Publication Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-OctreotateLucas, C., Goodman, S., Smith, J., Burge, M., Wyld, D. and Kumar, Ravi A. (2016). Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725 |
|
2015 Conference Publication A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Conference Publication Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare CancerWyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Conference Publication A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumorMichael, M., Pavlakis, N., Wyld, D., Link, E., Liauw, W., Kuru, N. and Hicks, R. (2015). A Phase II Study of Everolimus in patients with FDG-PET positive intermediate grade (Ki67 3-20%) pancreatic neuroendocrine tumor. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, March 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385 |
|
2015 Conference Publication A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancyKevat, D., Chen, M., Wyld, D., Fagermo, N. and Lust, K. (2015). A case of pulmonary carcinoid in pregnancy and review of carcinoid tumours in pregnancy. RCOG World Congress 2015, 12–15 April, Brisbane, Queensland, Australia, Brisbane, Queensland, Australia, 12–15 April 2015. Chichester, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/1471-0528.13370 |
|
2015 Conference Publication Patient understanding of research in a medical oncology settingRoberts, Natasha, Ives, Amy, Wyld, David and Cubitt, Annette (2015). Patient understanding of research in a medical oncology setting. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2 |
|
2015 Conference Publication Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional studyJan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385 |
|
2014 Conference Publication Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyraponeChan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2014 Conference Publication Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Locally advanced and metastatic pancreatic cancer: an assessment of the provision of chemotherapy at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATELee, K., Conway, L., Burge, M., Wyld, D. and Macfarlane, D. (2014). Novel succinate dehydrogenase subunit B intronic mutation in an Australian kindred with variable clinical and imaging phenotype necessitating different treatment modalities including 131-I MIBG and 177-Lutetium DOTATATE. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG. |
|
2014 Conference Publication Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (Lccrt) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (Lccrt). An assessment at a tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
|
2014 Conference Publication Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospitalChristie, Hayden, Burge, Matthew, Eastgate, Melissa and Wyld, David (2014). Time from diagnosis of rectal adenocarcinoma to commencement of long course chemoradiotherapy (Lccrt) for metropolitan versus rural patients referred to a Queensland tertiary referral hospital. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, Australia, 2-4 December, 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305 |
